Compare NRG Energy Inc (NRG) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NRG Energy Inc vs Natera Inc. Common Stock — how do they compare? NRG Energy Inc trades at $100.16 (market cap $22.53B), while Natera Inc. Common Stock trades at $394 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 2.5× NRG Energy Inc's market cap, and NRG Energy Inc pays a 1.77% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NRG Energy Inc for 63 Days and Natera Inc. Common Stock for 0 Days on average.
| NRG | NTRA | |
|---|---|---|
Market Cap | $22.53B | $57.03B |
Volume | 2,965,287 | 1,131,157 |
Sector | Utilities | Health |
52-Week High | $184.03 | $425.64 |
52-Week Low | $95.23 | $179.42 |
Typical Hold Time | 63 Days | 0 Days |
Enterprise Value | $46.49B | $56.18B |
Dividend Yield | 1.77% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NRG Energy trades at $100.85, down 5.19% on the day amid mixed earnings results, with recent Q1 and Q2 2026 EPS misses. The stock shows neutral technical signals with bearish moving averages, while fundamentals reflect strong revenue growth to $30.71B in 2025 and a solid ROE of 26.77%, though net margins are thin at 2.56%. Recent news highlights a major 1.2 GW Texas data-center power project as a growth driver.
Outlook is cautiously optimistic given analyst consensus favoring Buy (70.37%) and a $202.90 price target, implying significant upside. Key risks include execution on large capex projects, rising debt-to-asset ratio (56.42% in 2025), and competitive pressures in utilities. The stock offers value with a low P/S of 0.66 but requires monitoring of earnings consistency and leverage trends.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
